The functions of circulating tumor cells in early diagnosis and surveillance during cancer advancement-Reference-Cited by-同舟云学术

The functions of circulating tumor cells in early diagnosis and surveillance during cancer advancement

Published:2017-09-01 Issue:3 Volume:5 Page:135-138
ISSN:2224-4018
Container-title:Journal of Translational Internal Medicine
language:en
Short-container-title:

Author:

Wang Yuqiao¹,Zhou Ying²,Hu Zhiyuan²³

Affiliation:

1. The Cooper Union for the Advancement of Science and Art , New York , USA

2. Center for Neuroscience Research , School of Basic Medical Sciences , Fujian Medical University , Fuzhou , Fujian Province , China

3. CAS Key Laboratory of Standardization and Measurement for Nanotechnology , CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology , Beijing , China

Publisher

Walter de Gruyter GmbH

Reference19 articles.

1. Ashworth TR. A case of cancer in which cells similar to those in the tumours were seen in the blood after death. Med J Aust 1869;14: 146-7.

2. Nowell PC. The clonal evolution of tumor cell populations. Science 1976; 194: 23-8.95984010.1126/science.959840

3. Lodish H, Berk A. Cancer. In: McHenry B, editors. Molecular Cell Biology, 7th ed. New York: W. H. Freeman; 2012, pp. 1148-9.

4. Zhang D, Zhao L, Zhou P, Ma H, Huang F, Jin M, et al. Circulating tumor microemboli (CTM) and vimentin+ circulating tumor cells (CTCs) detected by a size-based platform predict worse prognosis in advanced colorectal cancer patients during chemotherapy. Cancer Cell Int 2017; 17: 6.

5. Kasimir-Bauer S, Hoffmann O, Wallwiener D, Kimmig R, Fehm T. Expression of stem cell and epithelial-mesenchymal transition markers in primary breast cancer patients with circulating tumor cells. Breast Cancer Res 2012; 14: R15.10.1186/bcr309922264265

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Future perspective: identification and validation of biomarkers using liquid biopsy;Peritoneal Tumor Microenvironment of Cancers on Cancer Hallmarks;2024

2. Circulating tumor DNA as liquid biopsy in lung cancer: Biological characteristics and clinical integration;Cancer Letters;2023-11

3. Aumolertinib in NSCLC with leptomeningeal involvement, harbouring concurrent EGFR exon 19 deletion and TP53 comutation: a case report;Journal of Thoracic Disease;2023-07

4. Efficacy relevance of PD-L1 expression on circulating tumor cells in metastatic breast cancer patients treated with anti-PD-1 immunotherapy;Breast Cancer Research and Treatment;2023-05-25

5. Multi-organ-on-chip approach in cancer research;Organs-on-a-Chip;2022-12